MedTrace Logo

A Research Study for Patients With Overactive Bladder

NCT00168454 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 313

Last updated 2013-11-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate whether injections of botulinum toxin Type A into the bladder are safe and effective in treating overactive bladder.

Conditions

Interventions

BIOLOGICAL

botulinum toxin Type A

botulinum toxin Type A injected into detrusor on Day 1

DRUG

Placebo

Placebo (normal saline) injected into detrusor on Day 1

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2008-01-31
Completion
2008-06-30

Countries

  • United States
  • Belgium
  • Canada
  • Germany
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00168454 on ClinicalTrials.gov